6-K: Report of foreign private issuer (related to financial reporting)
20-F: FY2024 Annual Report
6-K: Novartis Upgrades Mid-Term Guidance
6-K: Financial Report Q3 2024
6-K: Explanatory Note
6-K: Novartis Second Quarter and Half Year 2024 Condensed Interim Financial Report – Supplementary Data
6-K: Financial Report Q1 2024
Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)
Novartis AG | 20-F: FY2023 Annual Report
Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)
Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)
Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)
Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)
Novartis AG | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)
Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)
Novartis AG | 20-F: FY2022 Annual Report
Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)
Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)
Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)
Unlock the Full List